| Medical and Health Sciences | Lifetime | 260 | US 140 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 108 | US 42 | 99.98 |
| Cardiology and Cardiovascular Medicine | Lifetime | 61 | US 33 | 99.95 |
| Surgery | Lifetime | 365 | US 204 | 99.69 |
| Public, Environmental and Occupational Health | Lifetime | 677 | US 346 | 99.05 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 748 | US 409 | 98.04 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 574 | US 310 | 98.20 |
| Emergency Medicine | Lifetime | 917 | US 486 | 88.40 |
| Surgery | 2021-2025 | 67 | US 29 | 99.59 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 40 | US 24 | 99.85 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 141 | US 48 | 97.71 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 204 | US 88 | 96.34 |
| Public, Environmental and Occupational Health | 2021-2025 | 512 | US 194 | 95.04 |
| Health | 2021-2025 | 278 | US 113 | 92.08 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 469 | US 107 | 91.54 |
| Medical Physiology | 2021-2025 | 962 | US 352 | 83.49 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 744 | US 258 | 82.59 |
| Blood Pressure and Hypertension Studies | Lifetime | 18 | US 10 | 99.87 |
| Cardiac Health and Mental Health | Lifetime | 10 | US 6 | 99.78 |
| Cardiovascular Disease and Adiposity | Lifetime | 21 | US 16 | 99.83 |
| Cardiovascular Health and Risk Factors | Lifetime | 6 | US 5 | 99.86 |
| Cardiovascular Function and Risk Factors | Lifetime | 86 | US 61 | 99.82 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 85 | US 41 | 99.63 |
| Lipoproteins and Cardiovascular Health | Lifetime | 40 | US 24 | 99.77 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 63 | US 32 | 99.66 |
| Cardiovascular Health and Disease Prevention | Lifetime | 71 | US 33 | 99.50 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 16 | US 4 | 99.37 |
| Birth, Development, and Health | Lifetime | 230 | US 87 | 99.16 |
| Cardiac Imaging and Diagnostics | Lifetime | 323 | US 177 | 99.46 |
| Health, Environment, Cognitive Aging | Lifetime | 61 | US 27 | 98.79 |
| Nutritional Studies and Diet | Lifetime | 212 | US 98 | 99.19 |
| Heart Failure Treatment and Management | Lifetime | 217 | US 116 | 99.16 |
| Acute Myocardial Infarction Research | Lifetime | 269 | US 138 | 99.09 |
| Sodium Intake and Health | Lifetime | 107 | US 51 | 98.16 |
| Health disparities and outcomes | Lifetime | 663 | US 299 | 97.58 |
| Heart Rate Variability and Autonomic Control | Lifetime | 849 | US 380 | 97.50 |
| Peripheral Artery Disease Management | Lifetime | 520 | US 302 | 97.09 |
| Heart rate and cardiovascular health | Lifetime | 262 | US 90 | 85.58 |
| Sex and Gender in Healthcare | Lifetime | 953 | US 480 | 67.58 |
| Cardiac Health and Mental Health | 2021-2025 | 2 | US 1 | 99.70 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 1 | US 1 | 99.84 |
| Birth, Development, and Health | 2021-2025 | 10 | US 6 | 99.43 |
| Health, Environment, Cognitive Aging | 2021-2025 | 5 | US 3 | 98.96 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 14 | US 4 | 99.57 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 23 | US 9 | 99.49 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 23 | US 11 | 99.47 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 103 | US 30 | 98.49 |
| Health disparities and outcomes | 2021-2025 | 82 | US 31 | 98.01 |
| Nutritional Studies and Diet | 2021-2025 | 219 | US 54 | 96.78 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 189 | US 54 | 92.85 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 145 | US 31 | 79.48 |
| Sodium Intake and Health | 2021-2025 | 360 | US 87 | 77.01 |
| Healthcare Systems and Public Health | 2021-2025 | 776 | US 33 | 75.64 |
| Pharmaceutical Economics and Policy | 2021-2025 | 874 | US 283 | 71.79 |
